Figure 1.

Schematic comparison between the conventional treatment paradigm (A) in which first-line chemotherapy is continued until disease progression, effective maintenance therapy (B) in which de-escalation of first-line therapy minimizes cumulative toxicity without compromising progression-free survival, and ideal maintenance therapy (C) in which de-escalation to maintenance therapy minimizes cumulative toxicity while extending progression-free survival.